The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study

Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden

(2022) Yun-Han Wang et al.   BMJ Open

Association of Proton Pump Inhibitor and Infection and Major Adverse Clinical Events in Patients With ST-Elevation Myocardial Infarction: A Propensity Score Matching Analysis

(2022) Yuan-Hui Liu et al.   Frontiers in Medicine

Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study

(2022) Yan Hua Huang et al.   European Journal of Preventive Cardiology

Effectiveness and Safety of Histamine H2 Receptor Antagonists: An Umbrella Review of Meta‐Analyses

(2022) Rui Meng et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Curbing proton pump inhibitor overprescribing: Multifaceted strategies in an academic hospital

(2021) Léo Veremme et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients

(2021) Chen Chen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Managing Patients With Short-Term Mechanical Circulatory Support

(2021) Tim Balthazar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Potentially inappropriate medication (PIM) use and severe drug interactions (SDIs) in older adults with cancer

(2021) Amanda Hanora Lavan et al.   Journal of Geriatric Oncology

Proton Pump Inhibitor Use Before ICU Admission Is Not Associated With Mortality of Critically Ill Patients

(2020) Lin Shi et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline

(2020) Zhikang Ye et al.   BMJ-British Medical Journal

Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis

(2020) Ying Wang et al.   BMJ-British Medical Journal

PIC, a paediatric-specific intensive care database

(2020) Xian Zeng et al.   Scientific Data

Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational Study

(2020) Luis A. García Rodríguez et al.   Journal of Clinical Medicine

Frailty in Critical Care Medicine

(2020) Justin C. De Biasio et al.   ANESTHESIA AND ANALGESIA

Dermatologic Adverse Reactions to Proton Pump Inhibitors: A Synthetized Review

(2020) Antoine Salloum et al.   Journal of Cosmetic Dermatology

The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing

(2020) Thiruvinvamalai S. Dharmarajan   Journal of the American Medical Directors Association

Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection

(2020) Malin Inghammar et al.   CLINICAL INFECTIOUS DISEASES

Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group

(2019) Alan N. Barkun et al.   ANNALS OF INTERNAL MEDICINE

The physiology of the gastric parietal cell

(2019) Amy C. Engevik et al.   PHYSIOLOGICAL REVIEWS

Decreasing Overall and Inappropriate Proton Pump Inhibitor Use: Perspective From a Large Safety-Net Healthcare System

(2019) Derek Lin et al.   Clinical Gastroenterology and Hepatology

Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review

(2018) Timothy P. Shiraev et al.   Heart Lung and Circulation

Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor

(2018) Toshihisa Takeuchi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Cardioprotective effect of histamine H2 antagonists in congestive heart failure

(2018) Juan Zhang et al.   MEDICINE

Use of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study

(2018) Kasper Adelborg et al.   Clinical Epidemiology

Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU

(2018) Mette Krag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study

(2016) Remo Holanda de Mendonça Furtado et al.   American Journal of Cardiovascular Drugs

Histamine H 2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk

(2016) Peter J. Leary et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

(2016) Benjamin Lazarus et al.   JAMA Internal Medicine

Association of Proton Pump Inhibitors With Risk of Dementia

(2016) Willy Gomm et al.   JAMA Neurology

A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study

(2015) Yunju Jo et al.   Gut and Liver

Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care

(2015) Andrew T. Costarino et al.   Pediatric Critical Care Medicine

Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis

(2015) Allison A. Lambert et al.   PLoS One

Proton pump induced thrombocytopenia: A case report and review of literature

(2014) Avyakta Kallam et al.   PLATELETS

Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan

(2013) R. Iwakiri et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor

(2012) Shaun G. Goodman et al.   CIRCULATION

Comparison Between the Effect of Omeprazole and Rabeprazole on the Antiplatelet Action of Clopidogrel

(2010) Suksiri Siriswangvat et al.   CIRCULATION JOURNAL